Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • Genohub
    Registered Vendor
    • Mar 2013
    • 210

    #1

    Coverage and Read Depth Recommendations by Sequencing Application

    Genohub is in the process of developing an evolving coverage and read depth guide: https://genohub.com/recommended-sequ...y-application/ based on references in the field. We'd like to ask this community for feedback and references to improve this guide.

    - Genohub
  • Brian Bushnell
    Super Moderator
    • Jan 2014
    • 2709

    #2
    Whole-genome sequencing:

    I don't see why indel-calling needs 4x the coverage of SNP-calling; 20x per ploidy seems fine to me for indel-calling, as it does for snp-calling. In fact, I suggest you mention somewhere on the page that the recommendations are for diploid genomes; you state
    The coverage values below apply to most organisms while the read recommendations are for mammalian species with genome sizes of ~3Gb
    but that does not really cover the issue of ploidy.

    For CNVs... "1-8x" coverage seems really low to me. I would reject any data that calls virtually anything at 1x. It's important to mention the difference between amplified and unamplified libraries. I don't think amplified libraries are reliable for CNVs, due to amplification biases and randomness. Most of the time, you will probably see a 2x jump in coverage over a duplicated region using highly-amplified 8-fold coverage data... but I would not stake someone's life on that. The bias is reduced as you decrease the number of amplification cycles, but I don't know of a specific study that has analyzed this effect.

    Whole-exome sequencing:

    Calling a SNP homozygous at 3x coverage will be wrong (purely in terms of hom/het) ~1/8th of the time. I can hardly recommend a process that is wrong 1/8 of the time, though I should mention that when I wrote a variant caller, I got the best results when calling variants as low as 3x coverage. But I still don't recommend it as a guideline for planning things, particularly for exome-capture, which has an inherent ref-bias.

    I had very good luck in calling indels from exome-capture data (consistent in trio studies, etc) but I assume it may be highly bait-system dependent. I only know about the ones that were called successfully, not what was missed, and I assume the ref-bias from baits is much more severe on indels than SNPs. So the recommendation of not selecting exome-capture with the intention of looking for indels seems appropriate. But I would still highly recommend people with exome-capture data to look for indels.

    Transcriptome Sequencing/RNA-seq:

    If people are interested in differential splicing, you should encourage them to use the longest possible reads (and paired reads). Also - the recommendations you have there are for a number of reads; but what is important is the transcriptome coverage, which varies by genome size and % of genome that is coding. I suggest you make your recommendations in terms of transcriptome coverage rather than a set number of reads (which does not consider read length, genome size, or transcriptome size).

    I have not directly used the other categories so I'll defer to those who have.
    Last edited by Brian Bushnell; 05-12-2015, 07:37 PM.

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
      by SEQadmin2



      Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

      Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
      ...
      10-14-2026, 09:55 AM
    • SEQadmin2
      New Genomics Technologies Take Aim at Long-Standing Limits
      by SEQadmin2


      Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

      We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
      ...
      09-28-2026, 10:25 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, Yesterday, 11:13 AM
    0 responses
    19 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, Yesterday, 10:48 AM
    0 responses
    18 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-15-2026, 10:52 AM
    0 responses
    36 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-14-2026, 05:39 AM
    0 responses
    42 views
    0 reactions
    Last Post SEQadmin2  
    Working...